Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery


Arslan N., Ilgan S., Yuksel D., Serdengecti M., Bulakbasi N., Ugur Ö., ...More

CLINICAL NUCLEAR MEDICINE, vol.26, no.8, pp.683-688, 2001 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 8
  • Publication Date: 2001
  • Doi Number: 10.1097/00003072-200108000-00004
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.683-688
  • Keywords: computed tomography, In-111 octreotide, magnetic resonance imaging, medullary cancer of thyroid, Tc-99m (V) DMSA, ultrasonography, SOMATOSTATIN RECEPTORS, CARCINOMA, DIAGNOSIS, CANCER, LOCALIZATION, EXPRESSION

Abstract

Purpose: In this retrospective study, the authors evaluated the utility of In-111 octreotide (OctreoScan) and Tc-99m (V) DMSA scintigraphy for the localization of recurrent metastatic tumor foci in patients with medullary thyroid cancer (MTC) and compared the findings with those of conventional radiologic imaging methods.